|Bid||20.77 x 200|
|Ask||21.05 x 100|
|Day's Range||20.83 - 21.40|
|52 Week Range||20.60 - 30.10|
|Beta (3Y Monthly)||-0.07|
|PE Ratio (TTM)||6.80|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
FONAR Corporation (NASDAQ-FONR), Inventor of MR Scanning™, reported that its founder, chairman of the board and past president, Raymond V. Damadian, M.D. received the Excellence in Medicine award from the Chiari & Syringomyelia Foundation (CSF), on November 10, 2018, at Brooks’s, London, England. Dr. Damadian was introduced by Fraser C. Henderson, Sr., M.D., a neurosurgeon and a member of the steering committee for the Chiari & Syringomyelia Foundation and Professor Donlin Long, M.D., former Chairman of Neurosurgery at Johns Hopkins University.
Income from Operations increased 16% to $5.5 million, for the quarter ended September 30, 2018, versus same quarter one year earlier.Net Income decreased by 2% to $4.5 million.
NEW YORK, Oct. 25, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Stock Monitor: Fonar Post Earnings Reporting LONDON, UK / ACCESSWIRE / February 21, 2018 / Active-Investors.com has just released a free earnings report on Boston Scientific Corp. (NYSE: BSX ). If you ...